Building Resilience During the COVID-19 Pandemic: a Randomized Controlled Trial

Launched by MEDICAL UNIVERSITY INNSBRUCK · Apr 6, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at two different programs to help improve mental health during the COVID-19 pandemic. One program is called Resilience Training (RASMUS), which aims to build emotional strength, while the other is a relaxation technique called Progressive Muscle Relaxation (PMR). Researchers want to see which program is more effective in reducing stress and improving overall well-being. They will also study how these programs might change brain structure and function, including how different areas of the brain communicate with each other.

To participate in this trial, you need to be between the ages of 18 and 65, speak German fluently, and have certain levels of psychological distress as measured by specific questionnaires. It's important to note that individuals currently receiving psychological therapy or with certain psychiatric disorders are not eligible to join. If you decide to take part, you will be guided through one of the two programs and will also have the chance to contribute to valuable research that could help others facing similar challenges during this unprecedented time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • GSI-T score (Mini-SCL) ≥63,
• • BRS score \<3,
• • fluent German speakers,
• • written informed consent.
• Exclusion Criteria:
• • Any psychiatric disorder according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (verified by Mini International Neuropsychiatric Interview \[M.I.N.I.\] 7.0.2), a history of nicotine or caffeine dependence is acceptable,
• • currently engaged in any form of regular psychological therapy offered by psychologists and/or psychiatrists,
• • currently engaged in any form of (group) interventions from other disciplines (social work, pedagogy, coaching, alternative therapy etc.)